Severe Combined Immunodeficiency (SCID) disease affects 1 in 35,000 newborns annually, of which approximately 145…
Aaron Ogdahl29 November 2022
Leiden, The Netherlands, June 28, 2022 – Today, Batavia Biosciences announces that it will extend…
Aaron Ogdahl28 June 2022
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
Adenoviruses are being explored as vectors for cardiovascular gene therapy purposes against many heritable diseases.…
Aaron Ogdahl26 May 2022
Adenoviruses have been shown to be very effective vehicles for delivering genetic material to cells…
Claire Otjes25 April 2022
Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry…
Claire Otjes20 April 2022
Adenovirus (Ad) vectors are used to develop gene therapy products and vaccines. Decades of research…
Aaron Ogdahl11 April 2022
Adenoviruses have been explored for gene therapy purposes for many decades. They are DNA viruses,…
Aaron Ogdahl24 March 2022
